LAUSR

FSCN1 as a new druggable target in adrenocortical carcinoma

Sign Up to like & get
recommendations!
2 Published in 2023 at "International Journal of Cancer"

DOI: 10.1002/ijc.34526

Abstract: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a high risk of relapse and metastatic spread. The actin‐bundling protein fascin (FSCN1) is overexpressed in aggressive ACC and represents a reliable prognostic indicator. FSCN1 has… read more here.

Keywords: new druggable; druggable target; acc; adrenocortical carcinoma ... See more keywords